ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial
Trial details
- Registry ID
- NCT06828861
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialNCT06828861 | AARD | Phase 3 | Terminated | 2026-05-07Actual |
| The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialNCT07197034 | AARD | Phase 3 | Terminated | 2026-04-15Actual |
| Study to Evaluate ARD-101 in Adults Receiving Bariatric SurgeryNCT05215847 | AARD | Phase 2 | Completed | 2023-02-03Actual |
| Study to Evaluate ARD-101 in Adults With ObesityNCT05121441 | AARD | Phase 2 | Completed | 2022-11-09Actual |
| A Study of Oral ARD-101 in Patients With Prader-Willi SyndromeNCT05153434 | AARD | Phase 2 | Completed | 2024-09-24Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |